dm+d
424106006
Medicine Compliance Aid Stability
JanuviaMerck Sharp & Dohme Ltd
Merck Sharp & Dohme Ltd
Januvia
Tablets f/c 25mg, 50mg, 100mg
G1 · Green 1Stability data indicates that the drug is suitable for CAs and there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage for up to 28 days only based on manufacturer's stability data.
16 November 2022
Lactation Safety Information
Insulin, metformin or alternative approropriate antidiabetic drug
No published evidence of safety
Low to moderate levels anticipated in milk due to the drug’s properties
Infant hypoglycaemia would not be expected due to its mechanism of action
21 September 2020